The first experimental evidence to understand how dopaminergic deficiency occurs in the PD retina showed that there is reduced tyrosine hydroxylase immunoreactivity of dopaminergic cells in patients with Parkinson’s disease. The gene discussed is TH; the disease is Parkinson disease.